 |
Article Review/Hyperlink
|
Assent-3 Investigators
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomized trial in acute myocardial infarction
Lancet (Aug) 358:605-613, 2001
The full text of this paper is available from the Lancet. However, you must register at the Lancet site first as a non-subscriber (you can get there via the journals page of HDCN).
Once you have registered at the Lancet site, click on this link.
| Related Folders: |
|
|
